Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael White

Showing results (141-150 of 585) with videos related to

Pageof 59
Sort By:
Journal of Clinical Pharmacology|August 16, 2021
Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of AbuseC Michael White, Thom Browne, Anne N Nafziger
Connecticut Medicine|July 3, 2008
Heparin-induced thrombocytopenia: a review of current pharmacologic treatmentRipple Talati, Craig I Colemen, C Michael White
Pharmacotherapy|August 25, 2009
A clinician's perspective on rating the strength of evidence in a systematic reviewCraig I Coleman, Ripple Talati, C Michael White
Pharmacotherapy|March 2, 2006
Comparative safety and efficacy of urokinase and recombinant tissue plasminogen activator for peripheral arterial occlusion: a meta-analysisStephen Sander, C Michael White, Craig I Coleman
Clinical Pediatrics|October 26, 2017
Guilty Until Proven InnocentDanielle Hatt, Prachi Syngal, Michael White, et al.
The Annals of Pharmacotherapy|September 17, 2017
Should an LDL-Cholesterol Target-Based Approach Be Readopted?C Michael White, Erin R Weeda, Elaine Nguyen
The Annals of Pharmacotherapy|February 27, 2016
Role of Ivabradine in the Treatment of Patients With Cardiovascular DiseaseErin R Weeda, Elaine Nguyen, C Michael White
Journal of Comparative Effectiveness Research|November 19, 2013
Pharmacologic and nonpharmacologic thromboprophylactic strategies in atrial fibrillationTawkiful Alam, Christopher A Clyne, C Michael White
The Journal of Emergency Medicine|October 18, 2023
Simultaneous Cardiocerebral Infarction Associated with Postcoital ActivityCarl Pastore, Michael White, Michael Henry, et al.
Connecticut Medicine|October 9, 2002
Budesonide: its role in Crohn's disease therapyCraig I Coleman, Prabashni Reddy, C Michael White
Pageof 59

Showing results (141-150 of 585) with videos related to

Sort By:
Pageof 59
Journal of Clinical Pharmacology|August 16, 2021
Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of AbuseC Michael White, Thom Browne, Anne N Nafziger
Connecticut Medicine|July 3, 2008
Heparin-induced thrombocytopenia: a review of current pharmacologic treatmentRipple Talati, Craig I Colemen, C Michael White
Pharmacotherapy|August 25, 2009
A clinician's perspective on rating the strength of evidence in a systematic reviewCraig I Coleman, Ripple Talati, C Michael White
Pharmacotherapy|March 2, 2006
Comparative safety and efficacy of urokinase and recombinant tissue plasminogen activator for peripheral arterial occlusion: a meta-analysisStephen Sander, C Michael White, Craig I Coleman
Clinical Pediatrics|October 26, 2017
Guilty Until Proven InnocentDanielle Hatt, Prachi Syngal, Michael White, et al.
The Annals of Pharmacotherapy|September 17, 2017
Should an LDL-Cholesterol Target-Based Approach Be Readopted?C Michael White, Erin R Weeda, Elaine Nguyen
The Annals of Pharmacotherapy|February 27, 2016
Role of Ivabradine in the Treatment of Patients With Cardiovascular DiseaseErin R Weeda, Elaine Nguyen, C Michael White
Journal of Comparative Effectiveness Research|November 19, 2013
Pharmacologic and nonpharmacologic thromboprophylactic strategies in atrial fibrillationTawkiful Alam, Christopher A Clyne, C Michael White
The Journal of Emergency Medicine|October 18, 2023
Simultaneous Cardiocerebral Infarction Associated with Postcoital ActivityCarl Pastore, Michael White, Michael Henry, et al.
Connecticut Medicine|October 9, 2002
Budesonide: its role in Crohn's disease therapyCraig I Coleman, Prabashni Reddy, C Michael White
Pageof 59